altered early infant gut microbiota in children developing allergy up to 5 years of age
TRANSCRIPT
Linköping University Post Print
Altered early infant gut microbiota in children developing allergy up to 5 years of age
Ylva Sjögren, Maria Jenmalm, Malin Böttcher, Bengt Björkstén and Eva Sverremar-Ekström
N.B.: When citing this work, cite the original article.
The definitive version is available at www.blackwell-synergy.com:
Ylva Sjögren, Maria Jenmalm, Malin Böttcher, Bengt Björkstén and E Sverremar-Ekström, Altered early infant gut microbiota in children developing allergy up to 5 years of age, 2009, CLINICAL AND EXPERIMENTAL ALLERGY, (39), 4, 518-526. http://dx.doi.org/10.1111/j.1365-2222.2008.03156.x Copyright: Blackwell Publishing Ltd
http://www.blackwellpublishing.com/
Postprint available at: Linköping University Electronic Press http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-17517
Altered early infant gut microbiota in children developing allergy up to five years of age. Gut microbiota and allergy development. Ylva M. Sjögren1, Maria C. Jenmalm2, Malin F. Böttcher2, Bengt Björkstén3, Eva Sverremark-Ekström1
1 The Department of Immunology, the Wenner Gren Institute, Stockholm University, Stockholm, Sweden. 2 The Division of Paediatrics, the Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. 3 The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Corresponding author. Mailing address: Ylva M. Sjögren The Department of Immunology The Wenner-Gren Institute Arrhenius laboratory of Natural Sciences F5 Svante Arrhenius väg 16-18 Stockholm University 106 91 Stockholm Sweden Phone: +46 8 16 44 36 Fax: +46 8 6129542 E-mail: [email protected]
Word count. 4432
Sjögren 2
2
ABSTRACT
Background: Early colonization with bifidobacteria and lactobacilli is postulated to protect
children from allergy, while Clostridium difficile colonization might be associated with
allergic disease. Previous studies of the infant gut microbiota in relation to subsequent allergy
development have mostly employed culture dependent techniques, studied genera of bacteria
and the follow up period was limited to two years.
Objective: To relate gut microbiota in early infancy, notably bifidobacteria and lactobacilli at
species level, to allergy development during the first five years of life and study if
environmental factors influence the early infant gut microbiota.
Methods: Faecal samples were collected at one week, one month and two months after birth
from 47 Swedish infants, followed prospectively to five years of age. Bacterial DNA was
analysed with Real-time PCR and related to allergy development, family size as well as
endotoxin and Fel d 1 levels in house dust samples. Primers binding to Clostridium difficile,
four species of bifidobacteria, two lactobacilli groups and Bacteroides fragilis were used.
Children regarded as allergic manifested allergic symptoms and were skin prick test positive
during their first five years while non-allergic children were neither.
Results: Children who developed allergy were significantly less often colonized with
lactobacilli group I (Lactobacillus (L.) rhamnosus, L. casei, L. paracasei), Bifidobacterium
adolescentis and Clostridium difficile during their first two months. Infants colonized with
several Bifidobacterium species had been exposed to higher amounts of endotoxin and grew
up in larger families than infants harbouring few species.
Conclusion: A more diverse gut microbiota early in life might prevent allergy development
and may be related to the previously suggested inverse relationship between allergy, family
size and endotoxin exposure.
Key words
Gut microbiota, infant, allergy, siblings, endotoxin, Fel d 1, bifidobacteria, lactobacilli,
Clostridium difficile.
Abbreviations
AB Asthma bronchialis
AD Atopic dermatitis
ARC Allergic rhinitis/conjunctivitis
B. Bifidobacterium
C. Clostridium
DNA Deoxyribonucleic acid
EU Endotoxin units
Fel d 1 major allergen of cat (Felis domesticus)
G- Gram negative
G+ Gram positive
L. Lactobacillus
PCR Polymerase chain reaction
SPT Skin prick test
Sjögren 4
INTRODUCTION
The commensal gut microbiota, comprising 500-1000 different species of bacteria [1] is
essential for oral tolerance induction and gut homeostasis [2, 3]. Colonization of the neonate
starts immediately after birth and early colonizers are e.g. Escherichia coli, Streptococcus,
Bifidobacterium (B.) and Bacteroides (reviewed in [4]). Studies have shown differences in
the gut microbiota of children raised in affluent and non-affluent societies. For example, a
lower proportion of Swedish children harbour lactobacilli, compared to Estonian and
Ethiopian children [5, 6]. Also, Swedish children are colonized somewhat later and have a
less diverse enterobacterial microbiota than Pakistani infants [7]. Furthermore, colonization
with clostridia, including Clostridium (C.) difficile, has been associated with allergy
development up to two years in several studies [8-10]. Children not developing allergy during
their first two years have instead been shown to be more frequently colonized with
enterococci and bifidobacteria as infants [9]. However, the influence of the infant gut
microbiota on later allergy development needs to be further elucidated.
Type of delivery, diet and country of birth influence the infant gut microbiota [5-7, 11,
12]. Yet, other factors might also contribute to the colonization of the infant gut.
Interestingly, number of siblings associates weakly with amount of bifidobacteria, in faeces
from one month old infants [12]. Exposure to endotoxin, which is present in the outer
membrane of Gram-negative (G-) bacteria, is higher in Estonian compared to Swedish homes
[13]. Possibly, children living in an environment with high exposure to endotoxin might
harbour a more diverse gut microbiota as suggested previously [5]. Also, as the endotoxin
levels in house dust correlate with pet keeping [14], high levels of pet allergens could be
viewed as a marker of bacterial exposure. These factors are particularly interesting to relate to
the infant gut microbiota, as allergy development is inversely associated with number of
siblings and exposure to endotoxin [13, 15, 16].
4
Sjögren 5
As species differences among bifidobacteria in allergic and non-allergic children have
been reported previously [17], further studies of bacterial diversity within various genera of
bacteria are of interest. Most previous studies have employed cultivation dependent
techniques [9, 17]. Recently, sequencing of bacterial genomes has made it possible to study
presence and amounts of bacteria with molecular methods. The 16SrDNA and 23SrDNA of
bacteria, containing both variable and conserved regions, are often targeted for primer and
probe design thus facilitating the analysis of bacteria at species level [18]. One method using
these primers is real-time PCR, a method which is more sensitive and less time-consuming
than cultivation techniques [18].
Hence, we hypothesize that children who develop allergy have an altered early infant
gut microbiota, at species level, compared to children who do not develop allergy.
Furthermore, the gut microbiota is influenced by household factors known to be inversely
associated with allergy development i.e. family size and endotoxin and Fel d 1 exposure.
Therefore, the presence and amounts of certain gut microbes in early infancy were related to
subsequent allergy development up to five years of age and to family size as well as house
dust levels of endotoxin and Fel d 1. Real-time PCR was employed for analysis of the
following bacterial species; C. difficile, B. bifidum, B. longum, B. adolescentis, B. breve,
Bacteroides fragilis, Lactobacilli group I (L. rhamnosus, L. paracasei, L. casei) and
Lactobacilli group II (L. gasseri, L. johnsonii group). The Lactobacilli and Bifidobacterium
species were chosen due to their abundance in early faecal samples from infants [19, 20] and
their postulated role in allergy development [17]. Also, C. difficile has been associated with
allergy development [10]. Furthermore, a component from Bacteroides fragilis has recently
been shown to be a potent immunomodulator [21] and thus this bacteria was also included.
5
Sjögren 6
6
MATERIAL AND METHODS
Study population
The study population, including 123 Swedish children, has been described in detail by
Voor et al [22]. The children were born between March 1996 and October 1999 in Linköping,
Sweden. All were born at term and they had an uncomplicated perinatal period. Inclusion in
this study was based on availability of faecal samples at one week, one month and/or at two
months of age and known allergy status up to the age of five. In all, 47 infants were included.
Sixteen infants developed allergy during their first five years of life, while 31 remained non-
allergic throughout the study period (Table 1). The allergic children had shown symptoms of
allergic disease and at least one positive skin prick test (SPT) during their first five years of
life, while the non-allergic children had not shown symptoms of allergic disease, nor had a
positive SPT. The study was approved by the Regional Ethics Committee for Human
Research at Linköping University. The parents of all children gave their informed consent in
writing.
Table 1. Demographic data of the subjects. None of the differences between the non-allergic and allergic group were statistically significant (p>0.05).
Subjects n=47
Non-allergic n=31
Allergic n=16
Female subjects 23 (49%) 14 (45%) 9 (56%) Born with Caesarean section 3 (6%) 3 (10%) 0 (0%) Any atopic heredity 37 (79%) 22 (71%) 15 (94%) Allergic mother 13 (28%) 8 (26%) 5 (31%) Exclusively breastfed ≥ 2 months 45 (96%) 31 (100%) 14 (88%) Oral antibiotics ≤ 2 months 2 (4%) 2 (6%) 0 (0%) Pets 7 (15%) 6 (19%) 1 (6%) Number of family members 3 (3-8) + 3 (3-8) 3 (3-5) + Household area/individual (m2) 28 (18-47) + 28 (18-47) 27 (20-38) + + Three children were excluded due to unavailable data on family members. Median values of family members and household area/individual are shown with the range in brackets.
A clinical examination of the babies was made at three, six and twelve months and at
two and five years. At these occasions, skin prick tests were performed, and questionnaires
were completed regarding symptoms of allergy, use of antibiotics and family size. Atopic
dermatitis was defined as pruritic chronic or chronically relapsing dermatitis with typical
morphology and distribution. Asthma was defined as three or more episodes of bronchial
obstruction during the last 12-month period, of which at least one should be verified by a
physician. Allergic rhinitis/conjunctivitis was defined as rhinitis and/or conjunctivitis
following at least twice in one hour after allergen exposure and not in relation to an obvious
infection e.g. fever or a cold.
Skin prick tests, with fresh skimmed cow’s milk and thawed egg white, were performed
at all follow ups. From 12 months, the children were tested with cat allergen extract and at
two and five years also with birch- and timothy extracts (ALK, Hørsholm, Denmark). The
SPT was considered to be positive if the mean diameter of the wheal reaction was ≥3 mm.
Only three children were SPT positive at the first clinical examination at three months
of age. Therefore it is not likely that the allergic children were allergic already when the
faecal samples were collected (at one week, one month and two months after birth). At five
years of age, nine of the allergic children were SPT positive against inhalant allergens while
seven of the allergic children manifested earlier food sensitization. Fifteen children had
atopic dermatitis (AD) during their first five years of life. At age five, six children had
allergic rhinitis/conjunctivitis (ARC) either in combination with asthma (AB) (three) or
without (three), and one child had asthma in combination with atopic dermatitis. Thus, seven
children were included in the group ARC/AB ever, and nine children were included in the
group AD only.
Sjögren 8
The demographic data were similar in infants who developed and did not develop
allergy (Table 1). The majority of the children, in the total cohort, had a history of atopic
disease in the immediate family (79%). In total, three children were delivered with caesarean
section. During their first two months, when the faecal samples were collected, almost all
(96%) in the total cohort were exclusively breastfed and only two infants received antibiotics.
Extraction of DNA from faecal samples
Faecal samples were collected at home when the infants were one week (collected at
day five or six), one month and two months old. Approximately one gram voided stool was
collected into sterile plastic containers by the parents and frozen at -20ºC. The stool sample
was brought in a plastic bag with ice to the research nurse who stored the sample at -70ºC
until analysis.
Qiamp DNA Stool Mini Kit™ (Qiagen, Hilden, Germany) was used for the isolation of
DNA from the faecal samples. According to the manufacturer’s instructions, 180-220 mg
frozen faeces were subjected to DNA isolation procedures. A protocol for increasing the
bacterial DNA over human DNA was used. The concentration of nucleic acids was measured
with BIO-RAD Smartspec (Bio-Rad laboratories, Hercules, CA, USA) at 260 nm using BIO
RAD trUView Disposable Cuvettes (Bio-Rad laboratories, Hercules, CA, USA).
Reference bacterial DNA
Reference DNA from B. adolescentis DSM 20083, B. bifidum DSM 20456, B. breve
DSM 20213, B. infantis DSM 20088, B. longum DSM 20219, C. difficile DSM 21296, L.
gasseri DSM 20243 and L. rhamnosus DSM 20711 were purchased from BIOTECHON
Diagnostics (Potsdam, Germany). Also reference DNA from B. adolescentis ATCC 15703D,
C. difficile ATCC 9689D, B. breve ATCC 15700D and B. infantis ATCC 15697D were
8
Sjögren 9
purchased from LGC Promochem (Borås, Sweden). The bacterial DNA was solved in 1X TE
buffer (pH 8) or water according to the manufacturer´s instructions and stored at -200C.
Real-time PCR for quantification of bacterial DNA
For concentrations and sequences of primers see table 2. The primers were used due to
their specificity in binding to the specific bacterial DNA, as well as for their suitability in
SYBR Green PCR chemistry. The primers for B. longum, Bacteroides fragilis, Lactobacilli
group I and Lactobacilli group II were designed by us. The primer for B. longum was
designed to detect the different suggested subspecies of B. longum including B. infantis [23].
Since different Lactobacilli species have shown similarities in the 16SrDNA-23SrDNA we
choose to design primers directed towards two of these groups [24], here referred to as
Lactobacilli group I and Lactobacilli group II. Primer design was performed by running
published sequences, retrieved from Nucleotide Database at National Center for
Biotechnology Information (NCBI), of the above bacteria’s genes for 16SrRNA and
23SrRNA in Primer Express software version (Applied Biosystems) using TaqMan MGB
Quantification protocol. This resulted in primers suitable for SYBR green PCR chemistry i.e.
with a melting temperature of 58-60° and a GC content of 30-80%. Suggested forward and
reverse primers were then tested for their specificity using Basic Local Alignment Serach
Tool (BLAST) under NCBI (www.ncbi.nlm.nih.gov/BLAST). Primer sets binding to the
appropriate bacterial DNA were then tested with the reference bacteria and optimization of
primer concentrations was performed. The concentrations giving the lowest CT value
combined with no primer-dimer, as seen by melting curve analysis, were chosen. Regarding
some of the already published primers, adjustments of primer-concentrations needed to be
done to fit SYBR Green chemistry (Table 2).
9
Sjögren 10
Table 2. Sequences and concentrations of primer sets used. The specific primers amplified regions in the 16SrRNA for B. bifidum, B. breve, B. longum or C. difficile and in the 16S-23SrRNA intragenic spacer for B. adolescentis, Lactobacilli gr. I, Lactobacilli gr. II or Bacteroides fragilis. Bacteria Sequence (5´ 3´) Conc.
(nM) Amplicon length
B. bifidum (39) F: CCACATGATCGCATGTGATTG R: CCGAAGGCTTGCTCCCAAA
F: 250 R: 250
278 bp
B. breve (39) F: CCGGATGCTCCATCACAC R: ACAAAGTGCCTTGCTCCCT
F: 200 R: 50
288 bp
B. longumt F: CAGTTGATCGCATGGTCTTCTG R: CGCGACCCCATCCCATA
F: 400 R: 650
54 bp
B. adolescentis (40) F: ATAGTGGACGCGAGCAAGAGA R: TTGAAGAGTTTGGCGAAATCG
F: 300 R: 150
71 bp
Lactobacilli gr. It F: AAGAAATTCGCATCGCATAACC R: TGCGCCCTTTGTAACTTAACC
F: 150 R: 650
62 bp
Lactobacilli gr. IIt F: GGAAGGCGAAAGATGATGGA R: GCTTGGCTTTCTCGATGACTTCT
F: 650 R: 400
62 bp
C. difficile (41) F: TTGAGCGATTTACTTCGGTAAAGA R: CCATCCTGTACTGGCTCACCT
F: 500 R: 500
157 bp
Bacteroides fragilist F: CCGTTATTCTCCACTCCGATACC R: TCATGTCAAAGATCGTTTGATTACAC
F: 400 R: 400
67 bp
t = this study, F=forward primer, R=reverse primer, bp=base pair. Conc.=concentration.
The SYBR Green real-time PCR was performed using 96-well detection plates
(ABgene, Epsom, UK) together with adhesive films (ABgene, Epsom, UK) in ABI prism
7000 (Applied Biosystem, Stockholm, Sweden). The Absolute Quantification protocol in
7000 System software version 1.2.3f2 (Applied Biosystems) was employed together with a
standard curve set up from known amounts of reference bacterial DNA. The standards were
diluted in 10-fold dilution series and ranged from 5 ng to 50 fg. All samples were performed
in triplicates. Each well contained 2xPower SYBR Green mastermix (Applied Biosystems,
Stockholm, Sweden), forward and reverse primer (MWG-Biotech, Edersburg, Germany),
DNA and water. The amplification was performed as follows: 2 min at 50°, 10 min at 95°
followed by 40 cycles of 15s at 95°C (denaturation) and 1 min at 60° (annealing and
10
Sjögren 11
extension). To determine the specificity of the PCR a melting curve analysis was performed
by slow heating from 60-99°C with continuous fluorescence collection.
To avoid detecting false positives, triplicates with CT values above 35 were considered
as negative. The Absolute Quantification protocol in 7000 System software calculated the
amount of specific bacterial DNA from the standard curve. The amount of the specific
bacterial DNA was then related to the total amount of nucleic acids in each sample. The
specific bacterial DNA is thus expressed as percent specific bacterial DNA of total nucleic
acids and referred to as relative amounts of specific bacterial DNA. The limit of detection
was 5*10-6 % specific bacterial DNA of total nucleic acids.
Endotoxin and Fel d 1 analyses
Dust samples were collected from carpets in the children´s homes once when the
children were 3-12 months old. The collection procedures as well as analyses are further
described in [13]. In short, the analyses were performed under sterile conditions with a
chromogenic Limulus Amebocyte Lysate assay. The lowest limit of detection of endotoxin
was 0.50 EU/mg dust and values below this detection limit was assigned the value 0.25
EU/mg. Fel d 1 were analysed by ELISA (Indoor Biotechnologies, Cardiff, UK) and the
lowest detection limit was 4 ng/g dust.
Statistics
Fisher’s exact test was performed to evaluate whether presence of bacteria at various
occasions differed between children developing and not developing allergy and for evaluation
of demographic markers. Mann-Whitney U test was performed to evaluate whether the two
populations had different amounts of specific bacterial DNA in their faeces and whether
infants with high (3-4) compared to low (0-2) number of Bifidobacterium species had been
11
Sjögren 12
exposed to different endotoxin levels. In addition, Mann-Whitney U test (with Monte Carlo
permutation as correction for ties) was used to evaluate whether the allergic and non-allergic
group differed regarding harbouring the different bacteria at several occasions. Spearman’s
rank coefficient was calculated to investigate whether relative amount of bacterial DNA
correlated with endotoxin units, Fel d 1 levels and number of family members. Any
association between number of Bifidobacterium species and number of family members were
calculated with Cuzick’s non-parametric test for trend. The two children, who received
antibiotics, while the samples were collected, were excluded from the analyses of
environmental factors and gut microbiota. Many statistical tests were performed and thus
some p-values close to 0.05 might be false significances. The study is unfortunately not
sufficiently powered to detect very low p-values. Importantly, it should be viewed as
exploratory and consequently p<0.05 were chosen as statistically significant. Noteworthy,
future larger studies are of importance to investigate if these results could be replicated.
12
Sjögren 13
RESULTS
Presence and amounts of bacteria
Bifidobacteria were detected in all infants in at least one of the three samples collected
during the first two months of life. The most commonly detected Bifidobacterium species
were B. longum and B. adolescentis (Table 3), and B. longum also occurred in the highest
amounts (Fig. 1). Bifidobacterium breve was the least common of the Bifidobacterium
species studied. Few infants were colonised with C. difficile. Bifidobacterium longum, B.
adolescentis and Bacteroides fragilis were commonly present already in one week old
infants, whereas the other bacteria tended to become more frequently detected as the infants
grew older. Lactobacilli occurred in lower amounts than bifidobacteria (Fig. 1). The two
infants who received antibiotics harboured few Bifidobacterium species. However, DNA
from Bacteroides fragilis constituted a major fraction of the nucleic acids purified from the
faecal samples of these children (close to one percent). Two of the three children who were
born with caesarean section harboured C. difficile. The samples from the two children who
were not exclusively breastfed did not appear to differ from the samples from exclusively
breastfed children.
B. adolescentis and Lactobacilli group I were more common in early infant faecal
samples from non-allergic compared to allergic children.
At one week of age, 23/25 (92%) of the non-allergic infants harboured B. adolescentis
and 12/25 (48%) harboured Lactobacilli group I, while only 8/13 (62%) and 1/13 (8%) of the
infants who developed allergy during their first five years were colonized with these bacteria
(p=0.03 and p=0.02 respectively, Table 3). Also, Bifidobacterium adolescentis, Lactobacilli
group I and C. difficile were more often detected in the three samples, obtained during the
13
Sjögren 14
Table 3. Proportion of infants colonized with Bifidobacterium, Lactobacillus, C. difficile and Bacteroides fragilis during the first two months of life. The numbers in the headers show the number of infants with available faecal samples at the different time points. The figures, after the different bacteria, show the percent of infants who were colonized with the bacteria. Infants who developed allergy during their first five years of life are in group A whereas infants who remained non-allergic throughout the study period are in group NA.
1 week (%) 1 month (%) 2 months (%) Bacteria All
n=38 NA
n=25A
n=13All
n=42NA
n=28A
n=14All
n=41 NA
n=27 A
n=14B. longum 84 80 92 90 86 100 90 89 93 B. adolescentis 82 92a 62a 69 75 57 83 85 79 B. bifidum 61 60 62 71 75 64 71 67 79 B. breve 37 40 31 43 43 43 49 56 36 ≥3 Bifidobacterium sp. 55 60 46 60 61 57 76 78 71 Lactobacilli group I 34 48b 8b 62 71 43 61 67 50 Lactobacilli group II 34 32 38 43 36 57 54 48 64 C. difficile 5 8 0 12 14 7 27 37 7 Bacteroides fragilis 61 56 69 57 54 64 59 59 57
ap =0.03, bp =0.02
Fig. 1. Relative amounts of B. longum and Lactobacilli gr. I at one week after birth in relation to allergy development up to five years of age. Open circles denote those infants who did not develop allergy (n=25) and filled circles show those who developed allergy during their first five years of life (n=13). The results are expressed as percent specific bacterial DNA of total amount nucleic acids. The short lines demonstrate the median values and the dotted line illustrates the detection limit. The p-value indicates the difference between the non-allergic and allergic group regarding the relative amounts of Lactobacilli gr. I.
first two months of life, from non-allergic infants than in the samples from allergic infants
(p=0.045, p=0.02 and p=0.03 respectively, Fig. 2). The colonization pattern of the other
bacteria was similar in infants who did and did not develop allergy (Table 3). The number of
stool samples, with three or more Bifidobacterium species, was also similar in the two groups
14
Sjögren 15
(Table 3). With the exception of Lactobacilli group I at one week (Fig. 1), the relative
amounts of the different bacteria did not differ in samples from infants who did and did not
become allergic.
Fig. 2. Number of occasions with detectable B. adolescentis, Lactobacilli group I and C. difficile during the first two months of life in relation to allergy development up to age five. The y-axis shows the percentage of infants who did (A, n=11) or did not develop allergy (NA, n=21) during their first five years of life. The bacteria were studied on three occasions during the first two months and the x-axis illustrates the number of occasions with detectable bacteria. As calculated with Mann-Whitney U test, the non-allergic children harboured B. adolescentis, Lactobacilli gr. I and C. difficile on more occasions than the allergic group (p=0.045, p=0.02 and p=0.03 respectively). None of the other investigated bacteria occurred at different occasions between the allergic and the non-allergic group. Children are only included if faecal samples from all occasions were available.
The allergic children were divided into two groups depending on their allergic
symptoms during their first five years (see study population). Nine children were included in
the atopic dermatitis only group (AD only) and seven children in the allergic
rhinitis/conjunctivitis and/or asthma ever group (ARC/AB ever). There was no difference
regarding the presence of any of the investigated bacteria between the AD only and the
ARC/AB ever group. As shown for the total allergic group, the AD only tended to be less
frequently colonized with B. adolescentis and Lactobacilli group I one week after birth
compared with the non-allergic group (p=0.06 and p=0.03, respectively). No other bacteria
differed in prevalence between the AD only group and the non-allergic group. Interestingly,
none of the bacteria investigated occurred differently between the ARC/AB ever group
compared with the non-allergic group (p= 0.16 and 0.36 for B. adolescentis and Lactobacilli
15
Sjögren 16
gr. I). However, the small numbers in each group when separating the children into the AD
only group (nine children) and the AB/ARC ever group (seven children) could greatly bias
the results.
Environmental factors influence the early infant gut microbiota.
The number of family members correlated significantly with the number of
Bifidobacterium species in faecal samples collected at one week and two months after birth
(p=0.04 and p=0.02, Table 4). Colonization with several (3-4) Bifidobacterium species, at
one week and two months of age tended to be associated with exposure to higher levels of
endotoxin than colonization with low numbers (0-2) of Bifidobacterium species (Fig. 3). This
was particularly obvious during the first week of life (Fig. 3b). There was no similar
correlation with the Fel d 1 levels in house dust.
Table 4. Number of faecal Bifidobacterium species (B. sp) during the first two months in relation to number of family members. The association between number of family members and number of B. sp was calculated with Cuzick’s non-parametric test for trend.
1 week 1 month 2 months family
members mean B. sp. (n infants)
mean B. sp.(n infants)
mean B. sp.(n infants)
3 2.5 (16) 2.6 (19) 2.7 (20) 4 2.5 (8) 2.9 (7) 3.1 (7) 5 3.0 (8) 2.7 (9) 3.1 (7) 6 3.5 (2) 3.5 (2) 3.5 (2) 8 4.0 (1) 4.0 (1) 4.0 (1)
p-value 0.04 0.17 0.02
In one- and two-month faecal samples the relative amounts of B. longum correlated or
tended to correlate with both endotoxin (r=0.41, p=0.02 and r=0.35, p=0.06) and Fel d 1
levels (r=0.38, p=0.03 and r=0.52, p=0.004). The relative amounts of C. difficile in two-
month faecal samples correlated negatively with Fel d 1 levels (r=-0.53, p=0.003), and also
tended to be inversely associated with Fel d 1 and endotoxin in one-month faecal samples
16
Sjögren 17
(r=-0.32 p=0.07 and r=-0.34, p=0.06 respectively). B. bifidum in faecal samples collected at
one month and two months was instead dependent on number of family members (r=0.46
p=0.006 and r=0.43, p=0.01 respectively). However, in one month samples, B. adolescentis
was negatively associated with number of family members (r=-0.34, p=0.04). Yet, the many
statistical tests performed, in combination with a limited sample size, could lead to false
significances.
Fig. 3. Number of faecal Bifidobacterium species in relation to endotoxin levels in house dust (EU/mg dust). The white boxes symbolize samples with two or less Bifidobacterium species (B. sp.) and the grey boxes those with three or more. In figure a and b, the number of B. sp. is measured in faecal samples collected at one week after birth. In figure c and d, the faecal samples were collected at one month and two months, respectively.
17
Sjögren 18
DISCUSSION
Infants who harboured Lactobacilli group I and B. adolescentis at one week after birth
were less likely to develop allergic disease during the first five years of life. Bifidobacterium
longum, which includes B. infantis, was the most prevalent Bifidobacterium species in the
infant faecal samples, which is in accordance with previous findings [20, 25]. Also B.
adolescentis was common, which is in agreement with some [26] but not all previous studies
[20, 25]. Both Lactobacilli group I and Lactobacilli group II were present in the early faecal
samples. Others have shown that Swedish infants harbour lactobacilli species, belonging to
these groups, during their first two months [19].
In most previous studies the early infant gut microbiota has been related to allergy
development during the first two years of life [8-10]. At this age, allergic manifestations are
mostly limited to the skin and gut. The children in our study were followed up to the age of
five, i.e. to an age when respiratory allergy and sensitization to inhaled allergens have
become the major clinical manifestation of allergy. Also, although our study size is somewhat
limited, allergy is well-defined, as both sensitization and symptoms were used to classify the
children as allergic and non-allergic. Interestingly, infants who harboured Lactobacilli group
I at one week of age less frequently developed allergic disease than infants lacking these
bacteria at the same time. Also, non-allergic children were more likely to harbour
Lactobacilli group I on several occasions during their first two months of life. When the
allergic children were grouped based on symptoms, it was shown that children who only
suffered from atopic dermatitis were less often colonized with Lactobacilli gr. I, one week
after birth, compared to the non-allergic children. These findings could be supported by
clinical studies, in which different strains of probiotic lactobacilli reduced the incidence of
infant eczema [27] and IgE-associated eczema [28]. However, bacterial colonization in the
seven children with respiratory allergy did not differ from bacterial colonization in the non-
18
Sjögren 19
allergic children. It is difficult to interpret the role of Lactobacilli group I on respiratory
allergies as only one child developed respiratory allergy without previous atopic dermatitis.
Furthermore, only seven children had developed allergic asthma and rhinitis/conjunctivitis at
age five. Children belonging to the AD only group, at age five, might develop respiratory
allergy later as a substantial proportion of sensitized children with atopic eczema develop
respiratory allergy before age seven [29].
Bifidobacterium adolescentis was more commonly detected in infants not developing
allergic disease, which is in contrast with two previous reports on allergic and non-allergic
infants [17] and children [30]. In contrast to these studies, our study population was
investigated in early infancy, before the onset of allergic disease. There may be a time
window of opportunity, only open very early in life, when microbial stimuli can influence the
development of the immune system [31]. Results from animal experiments support this
theory. In a murine model, B. infantis could restore oral tolerance in neonatal ex-germ-free
mice but not in adult mice [2]. Another study on allergic and non-allergic infants did not find
any association between allergic disease and colonization with B. adolescentis [32]. Yet, in
contrast to the study by Stsepetova [30], B. pseudocatenulatum were more frequently
detected in the allergic infants [32]. Studies show that different Bifidobacterium species elicit
different immune responses from diverse immune cells [33, 34]. Speculatively, the
colonization with several different species of commensal flora might lead to balanced
immune responses contributing to the development of a fully functional immune system
protecting children from allergy development. However, under certain conditions i.e. when
the gut microbiota is less diverse, certain species could appear to have a detrimental role in
allergic disease. This could also be the case for C. difficile. Previous studies suggest that
colonization early in life with C. difficile is more common among infants who develop
allergic disease than among infants who do not [10]. We could not confirm this, as infants
19
Sjögren 20
who developed allergy were less likely to be colonized with C. difficile during their first two
months. The low rate of C. difficile colonization combined with the relatively few number of
allergic children may explain the lack of a reverse association in our study. Nevertheless,
several studies, showing more clostridia, also indicate less other commensal bacteria in
children developing or suffering from allergy [8, 9, 35]. Therefore, it might rather be a gut
microbiota with lower diversity that is associated with allergy development. Interestingly, a
large recent study did not find any relationship between the presence of different bacteria and
allergy development up to 18 months of age [11], but indeed showed that infants who
developed allergy had a lower diversity in their gut microbiota [36]. In order to further
understand the influence of the gut microbiota on immune responses and allergy development
additional prospective studies and molecular studies are needed.
Lifestyle factors have been inversely associated with allergy development, and could
possibly influence the gut microbiota and how it establishes early in life. Interestingly, we
show that certain household factors are associated with the diversity of the bifidobacterial
flora. The number of Bifidobacterium species at one week and two months correlated
significantly with the number of family members. Higher counts of bifidobacteria [12] and
later acquisition of Clostridium species in infants with siblings [11] have been reported
previously. Thus, family members and siblings may rapidly contaminate the infant with a
commensal microbiota. This is further supported by experiments in rats showing that ex-
germfree rats encounter a normal gut microbiota almost as quickly when they are reared with
conventional rats as when they are inoculated with gut microbiota from conventional rats
[37].
Exposure to high levels of endotoxin in house dust was also associated with a more
diverse Bifidobacterium microbiota at one week and two months after birth. Endotoxin is a
component in G- bacteria and should probably be viewed as a marker of total bacterial
20
Sjögren 21
exposure in the homes and not as a factor directly related to the G+ bifidobacterial
microbiota. However, postnatal colonization with the G- and facultative aerobic
enterobacterial microbiota, is important to establish an appropriate environment for anaerobic
bacteria, such as bifidobacteria and Bacteroides [4]. Today, staphylococci are acquired the
first days after birth among Swedish infants, while it takes up to two months before most
infants have achieved an enterobacterial microbiota [38]. Speculatively, high bacterial
exposure may lead to early colonization with appropriate facultative aerobic bacteria, which
in turn would facilitate colonization of commensal anaerobic bacteria. The positive
association between endotoxin and Fel d 1 levels in house dust with the relative amount of B.
longum, and the inverse relationship with C. difficile, would support this possibility. Many
statistical tests were performed and p-values close to 0.05 might be false significances. Yet,
there are several indications in this study that larger families and more microbial exposure
lead to a gut flora with higher diversity. These data are also in line with the finding that
certain bacteria were less frequently detected in infants developing allergy. However, future
studies, with different and larger cohorts, are needed to verify these results. It will also be
necessary to perform more detailed studies of how a diverse microbiota, or certain species of
bacteria, influences infant immune responses. How these immune responses relate to allergy
development also needs to be further explored.
In conclusion, children who develop allergic disease were less often colonized with
Lactobacilli group I, B. adolescentis and C. difficile during their first two months of life. As
family size and endotoxin exposure appeared to influence the Bifidobacterium flora, a more
diverse gut microbiota early in life could, to some extent, explain the inverse association
between these household factors and allergy development.
21
Sjögren 22
ACKNOWLEDGMENTS
We are grateful to all children and parents participating in this study and to the
following people at Linköping University Hospital; research nurse Lena Lindell, laboratory
technologist Ann-Marie Fornander and Dr Sara Tomicic for excellent assistance and Dr Karel
Duchén for clinical evaluation of the children. We are also grateful to Tiina Rebane at Tartu
University Clinics, Jan-Olov Persson at Stockholm University for statistical help and
Elisabeth K. Norin at Karolinska Institutet for critically reading the manuscript.
This work was supported by the Ekhaga foundation, the Cancer and Allergy
foundation, Mjölkdroppen, the Magnus Bergvall foundation, the Swedish Research Council
(57X-15160-05-2 and 74X-20146-01-2), the National Swedish Association against Allergic
Diseases, the National Heart and Lung Association and the Swedish Foundation for Health
Care Sciences and Allergy Research.
22
Sjögren 23
REFERENCES
1. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol 2004; 5:569-73.
2. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159:1739-45.
3. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-41.
4. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69:1035S-45S.
5. Sepp E, Julge K, Vasar M, Naaber P, Björkstén B, Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997; 86:956-61.
6. Bennet R, Eriksson M, Tafari N, Nord CE. Intestinal bacteria of newborn Ethiopian infants in relation to antibiotic treatment and colonisation by potentially pathogenic gram-negative bacteria. Scand J Infect Dis 1991; 23:63-69.
7. Adlerberth I, Carlsson B, de Man P et al. Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Acta Paediatr Scand 1991; 80:602-10.
8. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-34.
9. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108:516-20.
10. Penders J, Thijs C, van den Brandt PA et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56:661-67.
11. Adlerberth I, Strachan DP, Matricardi PM et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007; 120:343-50.
12. Penders J, Thijs C, Vink C et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511-21.
13. Böttcher MF, Björkstén B, Gustafson S, Voor T, Jenmalm MC. Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy 2003; 33:295-300.
23
Sjögren 24
14. Heinrich J, Gehring U, Douwes J et al. Pets and vermin are associated with high endotoxin levels in house dust. Clin Exp Allergy 2001; 31:1839-45.
15. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000; 55:S2-10.
16. Braun-Fahrländer C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
17. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001; 30:43-47.
18. Matsuki T, Watanabe K, Tanaka R. Genus- and species-specific PCR primers for the detection and identification of bifidobacteria. Curr Issues Intest Microbiol 2003; 42:61-69.
19. Ahrné S, Lönnermark E, Wold AE et al. Lactobacilli in the intestinal microbiota of Swedish infants. Microbes Infect 2005; 7:1256-62.
20. Sakata S, Tonooka T, Ishizeki S et al. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiol Lett 2005; 243:417-23.
21. Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 2006; 6:849-58.
22. Voor T, Julge K, Böttcher MF, Jenmalm MC, Duchén K, Björkstén B. Atopic sensitization and atopic dermatitis in Estonian and Swedish infants. Clin Exp Allergy 2005; 35:153-59.
23. Klein G. International Committee on Systematics of Prokaryotes; Subcommittee on the taxonomy of Bifidobacterium, Lactobacillus and related organisms: Minutes of the meetings, 1 and 2 April 2005, Stuttgart-Hohenheim, Germany. Int J Syst Evol Microbiol 2006; 56:2501-03.
24. Song Y, Kato N, Liu C, Matsumiya Y, Kato H, Watanabe K. Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA. FEMS Microbiol Lett 2000; 187:167-73.
25. Grönlund MM, Gueimonde M, Laitinen K et al. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007; 37:1764-72.
26. Suzuki S, Shimojo N, Tajiri Y, Kumemura M, Kohno Y. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007; 37:506-11.
27. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 200; 357:1076-79.
24
Sjögren 25
28. Abrahamsson TR, Jakobsson T, Böttcher MF et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1174-80.
29. Lowe AJ, Hosking CS, Bennett CM et al. Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis. Clin Exp Allergy 2007; 37:1624-31.
30. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007; 51:260-69.
31. Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007;212:441-52.
32. Gore C, Munro K, Lay C et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 2008; 121:135-40.
33. Young SL, Simon MA, Baird MA et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 2004; 11:686-90.
34. He F, Morita H, Ouwehand AC et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 2002; 46:781-85.
35. Böttcher MF, Nordin EK, Sandin A, Midtvedt T, Björkstén B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30:1590-96.
36. Wang M, Karlsson C, Olsson C et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008; 121:129-34.
37. Midtvedt T, Carlstedt-Duke B, Hoverstad T, Midtvedt AC, Norin KE, Saxerholt H. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. Appl Environ Microbiol 1987; 53:2866-71.
38. Adlerberth I, Lindberg E, Åberg N et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr Res 2006; 59:96-101.
39. Matsuki T, Watanabe K, Fujimoto J et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004; 70:167-73.
40. Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 2005; 71:2318-24.
25